Entity Addresses, Address Type [Axis]
Business Contact [Member]
Related and Nonrelated Parties [Axis]
Sanovas Ophthalmology LLC [Member]
Related Party [Member]
Class of Stock [Axis]
Series F Preferred Stock [Member]
Equity Components [Axis]
Common Stock [Member]
Additional Paid-in Capital [Member]
Stock Subscription Receivable [Member]
Retained Earnings [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Exchange Agreement [Member]
Business Acquisition [Axis]
D N A G P S Inc [Member]
Vendor [Member]
Antidilutive Securities [Axis]
Share-Based Payment Arrangement, Option [Member]
Pre-funded Warrant [Member]
Warrant [Member]
Title and Position [Axis]
Officer [Member]
Halo Management LLC [Member]
Plan Name [Axis]
2017 Equity Incentive Plan [Member]
Statistical Measurement [Axis]
Minimum [Member]
Maximum [Member]
Stock Option One [Member]
Stock Option Two [Member]
Jerry Katzman MD [Member]
Virender Ahluwalia [Member]
Herbert Gould MD [Member]
Dessy Boneva MD [Member]
Vinay Mehindru MD [Member]
Warrant One [Member]
Warrant Two [Member]
Measurement Input Type [Axis]
Measurement Input, Risk Free Interest Rate [Member]
Measurement Input, Price Volatility [Member]
Measurement Input, Expected Dividend Rate [Member]
Measurement Input, Share Price [Member]
Income Tax Authority, Name [Axis]
Federal Income Tax [Member]
Tax Period [Axis]
No Expiration Date [Member]
Expire in 2034 [Member]
State Income Tax [Member]
Entity Addresses [Table]
Entity Addresses [Line Items]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference [Text Block]
Contact Personnel Name
Defined Benefit Plan [Table]
Defined Benefit Plan Disclosure [Line Items]
ASSETS
Current Assets
Cash
Total Current Assets
Equipment, net of accumulated depreciation of $276 and $251 at March 31, 2025 and December 31, 2024, respectively
Operating lease right-of-use asset
Security deposit
TOTAL ASSETS
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Liabilities
Current Liabilities
Accounts payable and accrued liabilities
Due to related parties
Shareholders’ notes payable
Lease liability – short term portion
Accrued interest payable
Total Current Liabilities
Lease liability – long term portion
Total liabilities
Stockholders’ Deficit:
Preferred stock, $0.0001 par value; 40,000,000 shares authorized; Series F preferred stock - 3,000,000 shares designated, 0 issued and outstanding at March 31, 2025 and December 31, 2024
Common stock, $0.0001 par value; 80,000,000 shares authorized; 18,522,295 shares issued and outstanding at March 31, 2025 and December 31, 2024
Additional paid in capital
Stock subscription receivable
Accumulated deficit
Total Stockholders’ Deficit
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT
Statement [Table]
Statement [Line Items]
Accumulated depreciation
Preferred stock, par value
Preferred stock, shares authorized
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Income Statement [Abstract]
Revenues
Operating expenses:
General and administrative
Research and development
Stock-based compensation
Total operating expenses
Interest expense, net
Net loss
Net loss per share, basic
Net loss per share, diluted
Weighted average number of common shares outstanding during the period- basic
Weighted average number of common shares outstanding during the period- diluted
Balance
Balance, shares
Balance
Stock based compensation expense
Net loss
Retirement of due to Sanovas through the issuance of shares of common stock to Sanovas Ophthalmology LLC
Retirement of due to Sanovas through the issuance of shares of common stock to Sanovas Ophthalmology LLC, shares
Shares issued to investors
Shares issued to investors, shares
Settlement of account payable through issuance of common stock
Settlement of account payable through issuance of common stock, shares
Stock subscribed by investor
Stock subscribed by investors, shares
Stock issued to vendor
Stock issued to vendor, shares
Exercise of stock options
Exercise of stock options, shares
Collection of stock subscription receivable
Balance
Balance, shares
Statement of Cash Flows [Abstract]
Cash Flows From (Used In) Operating Activities
Adjustments to reconcile net loss to net cash (used in) operating activities
Non-cash items:
Stock-based compensation expense
Depreciation expense
Stock issued for services provided
Amortization of ROU asset
Expenses allocated by Sanovas on behalf of Company
Changes in operating assets and liabilities:
Increase in accounts payable and accrued liabilities
Increase in security deposit
Payment of lease liability
Increase in accrued interest
Total adjustments
Net cash (used in) operating activities
Cash Flows From Financing Activities
Proceeds from sale of common stock
Proceeds from collection of stock subscription receivable
Proceeds from exercise of stock options and warrants
Advances from related parties
Advances from related parties, net
Net cash provided by financing activities
Net increase (decrease) in cash
Cash at beginning of period
Cash at end of period
Supplemental information:
Interest paid
Income taxes paid
Operating lease at inception
Retirement of due to Sanovas through the issuance of common stock to Sanovas Ophthalmology LLC (Note C)
Settlement of account payable through the issuance of common stock
Accounting Policies [Abstract]
HISTORY, BUSINESS PURPOSE, LIQUIDITY AND GOING CONCERN
SIGNIFICANT ACCOUNTING POLICIES
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS
Equity [Abstract]
COMMON AND PREFERRED STOCK
STOCK PLAN
Warrants
WARRANTS
Debt Disclosure [Abstract]
SHAREHOLDERS’ NOTES PAYABLE
Lease
LEASE
Income Tax Disclosure [Abstract]
INCOME TAXES
Subsequent Events [Abstract]
SUBSEQUENT EVENTS
Basis of Presentation
Cash Equivalents
Use of Estimates
Income Taxes
Income (Loss) Per Common Share
Stock-based compensation
Research and Development costs
Property and Equipment
Leases
Recent Accounting Pronouncements
SCHEDULE OF RELATED PARTY TRANSACTIONS
SCHEDULE OF STOCK OPTION ACTIVITY
SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE
SCHEDULE OF STOCK OPTIONS FAIR VALUE ASSUMPTIONS
SCHEDULE OF WARRANTS ACTIVITY
SCHEDULE OF WARRANTS OUTSTANDING
SCHEDULE OF WARRANTS FAIR VALUE ASSUMPTIONS
SCHEDULE OF LEASE LIABILITY MATURITY
SCHEDULE OF LEASE-RELATED ASSETS AND LIABILITIES
SCHEDULE OF DEFERRED TAX ASSETS
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Shares issued for acquisitions
Accumulated deficit
Liabilities
Other liabilities
Issuance of shares for settlement
Payment of expenses
Issuance of shares for settlement
Payment for settlement
Antidilutive Security, Excluded EPS Calculation [Table]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share
Property and equipment useful life
Related Party Transaction [Table]
Related Party Transaction [Line Items]
Balance due to Sanovas – beginning of period
Costs of Sanovas allocated to the Company
Retirement of due to Sanovas through the issuance of shares to Sanovas Ophthalmology
Cash advances from Sanovas to the Company, net
Balance due to Sanovas - end of period
Related party cost
issuance of shares of common stock
Advance funds received
Stock, Class of Stock [Table]
Class of Stock [Line Items]
Preferred stock shares authorized
Stock issued during period
Share based compensation arrangement by share based payment award options cancelling
Issuance of stock option were exercised
Stock option exercised for cash payment
Share offering price
Proceeds from issuance of common stock
Subscription receivable
Preferred stock shares outstanding
Preferred stock, voting right
Preferred stock, protective features
Preferred stock, dividend
Preferred stock conversion basis
Preferred stock conversion terms
Proceeds from issuance of preferred stock
Stock issued during period, values
Options Issued, Options outstanding, beginning balance
Weighted-Average Exercise Price, Options outstanding beginning balance
Options Issued, Granted
Weighted-Average Exercise Price, Granted
Options Issued, Canceled
Weighted-Average Exercise Price, Canceled
Options Issued, Forfeited
Weighted-Average Exercise Price, Forfeited
Options Issued, Exercised
Weighted-Average Exercise Price, Exercised
Options Issued, Options outstanding, ending balance
Weighted-Average Exercise Price, Options outstanding ending balance
Options Issued, Forfeited
Options Issued, Exercised
Accumulated Other Comprehensive Income (Loss) [Table]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Exercise Price
Number Outstanding
Weighted Average Remaining Contractual Life
Number Exercisable
Risk-free interest rates
Expected life in years
Expected volatility
Expected dividend yield
Fair value common stock
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Common stock shares reserved for future issuance
Stock option expense
Unrecognized compensation expense
Weighted-average period for recognition
Shares available for issuance
Fair value of option grant price per share
Schedule Of Warrants Activity
Warrants Issued, Warrants outstanding, beginning balance
Weighted-Average Exercise Price, Warrants outstanding, beginning balance
Warrants Issued, Granted
Weighted-Average Exercise Price, Granted
Warrants Issued,Canceled and expired
Weighted-Average Exercise Price, Canceled and expired
Warrants Issued, Exercised
Weighted-Average Exercise Price, Exercised
Warrants Issued, Warrants outstanding, ending balance
Weighted-Average Exercise Price, Warrants outstanding, ending balance
Warrants Issued,Canceled and expired
Exercise Price
Number Outstanding
Weighted Average Remaining Contractual Life
Number Exercisable
Fair Value Measurement Inputs and Valuation Techniques [Table]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrant measurement input
Expected life in years
Warrant issued to purchase common stock
Warrant exercise price
Warrant shares
Fair value of option grant price per share
Common stock exchanged for warrants
Debt instrument, face amount
Interest rate
Maturity date
Extended maturity date
Proceeds from exercise of warrants
Notes payable
Interest expense
Accrued interest
Schedule Of Lease Liability Maturity
2025
2026
2027
Total payments
Less interest
Total liability
Schedule Of Lease-related Assets And Liabilities
Right-of-use asset, net
Lease liability -long term
Lease liability – short term
Lease description
Operating lease term
Security deposit
Discount rate
Lease payments
Lease payments per month
Lease payments over month
Net operating loss carryforwards
Accrued expenses
Stock compensation
Capitalized R&D costs, net
Intangible asset, net
Accrued interest
Subtotal
Less valuation allowance
Net deferred tax asset
Operating Loss Carryforwards [Table]
Operating Loss Carryforwards [Line Items]
Description of operating loss carryforwards, limitations on use
Operating loss carryforwards
Gross deferred tax assets
Deferred tax valuation allowance
Stock Subscription Receivable [Member]
Settlement of accounts payable through issuance of shares.
Stock issued during period shares settlement of accounts payable.
Sanovas Ophthalmology LLC [Member].
Vendor [Member]
Pre-funded Warrant [Member]
Costs of related party allocated.
Halo Management LLC [Member]
Stock issued during period shares stock subscribed by investors
Stock subscription receivable
2017 Equity Incentive Plan [Member].
Stock Option One [Member]
Stock Option Two [Member]
Warrants Disclosure [Text Block]
Jerry Katzman MD [Member]
Virender Ahluwalia [Member]
Herbert Gould MD [Member]
Dessy Boneva MD [Member]
Vinay Mehindru MD [Member]
Share based compensation arrangement by share based payment award non-options outstanding weighted average exercise price granted.
Share based compensation arrangement by share based payment award non-options outstanding weighted average exercise price.
Share based compensation arrangement by share based payment award non-options outstanding weighted average exercise price cancelled.
Share based compensation arrangement by share based payment award non-options outstanding weighted average exercise price exercised.
Schedule Of Warrant Outstanding [Table Text Block]
Warrant One [Member]
Warrant Two [Member]
Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average remaining contractual terms.
Share based compensation arrangement by share based payment award non option equity instruments exercisableNumber.
Schedule of share based payment award warrants valuation assumptions.
Share based Compensation Arrangement By Share based Payment Award Warrant Fair Value Assumptions Expected Term 1.
Exchange Agreement [Member]
Schedule Of Lease Related Assets And Liabilities [Table Text Block]
Stock issued during period value stock subscribed by investors.
Operating lease at inception.
Extended maturity date.
Deferred tax assets tax stock compensation.
Deferred tax assets capitalized research and development costs net.
Deferred tax assets accrued interest.
No Expiration Date [Member]
Federal Income Tax [Member]
State Income Tax [Member]
Expire in 2034 [Member]
Stockholder equity.
Assets, Current
Assets
Liabilities, Current
Liabilities [Default Label]
Stockholders' Equity Note, Subscriptions Receivable
Equity, Attributable to Parent
Liabilities and Equity
Operating Expenses
Shares, Outstanding
StockholderEquity
Other Noncash Income (Expense)
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities
Net Cash Provided by (Used in) Operating Activities
Net Cash Provided by (Used in) Financing Activities
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations
Compensation Related Costs, Policy [Policy Text Block]
Debt Conversion, Converted Instrument, Amount
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceGranted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceExercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber
SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantFairValueAssumptionsExpectedTerm1
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
Lessee, Operating Lease, Liability, to be Paid
Operating Lease, Liability
Lease Deposit Liability
Deferred Tax Assets, Valuation Allowance
Deferred Tax Assets, Net of Valuation Allowance